Erlotinib hydrochloride (Tarceva)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Erlotinib hydrochloride (Tarceva), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery [Phase 1]